Shatovisha Dey, Ph.D.

Research Scientist II

Ph.D. University of Arkansas

Shatovisha’s research interests are in developing novel strategies for in vivo CRISPR/Cas9 delivery. She received her Ph.D. at the University of Arkansas, where her work utilizing GWAS and NGS approaches contributed towards development of marker-assisted selection of broilers against pulmonary hypertension. During her post-doctoral research, she worked in the area of oncogenetics, particularly breast and pancreatic cancers, with the goal of developing markers for early detection and therapeutic modalities for the diseases. Her work delineated novel mechanisms of miRNA-29 in the regulation of pancreatic diseases, such as pancreatitis and pancreatic ductal adenocarcinoma (PDAC) using genetically engineered mouse models.

At the Gene Editing Institute, her research focus is on utilizing her mechanistic and clinical experience to develop new in vivo CRISPR delivery strategies in the context of lung squamous cell carcinoma.